Elite Diagnostic Statistics

Total Valuation

Elite Diagnostic has a market cap or net worth of JMD 650.26 million. The enterprise value is 1.04 billion.

Market Cap	650.26M
Enterprise Value	1.04B

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Elite Diagnostic has 353.40 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	353.40M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	17.29%
Owned by Institutions (%)	28.82%
Float	182.10M

Valuation Ratios

The trailing PE ratio is 32.20.

PE Ratio	32.20
Forward PE	n/a
PS Ratio	0.79
PB Ratio	1.30
P/TBV Ratio	1.30
P/FCF Ratio	6.85
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.77, with an EV/FCF ratio of 10.95.

EV / Earnings	51.50
EV / Sales	1.26
EV / EBITDA	4.77
EV / EBIT	12.17
EV / FCF	10.95

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.87.

Current Ratio	0.83
Quick Ratio	0.80
Debt / Equity	0.87
Debt / EBITDA	2.00
Debt / FCF	4.59
Interest Coverage	1.90

Financial Efficiency

Return on equity (ROE) is 4.13% and return on invested capital (ROIC) is 5.50%.

Return on Equity (ROE)	4.13%
Return on Assets (ROA)	5.05%
Return on Capital (ROIC)	5.50%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.78
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.36% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+6.36%
50-Day Moving Average	2.10
200-Day Moving Average	1.75
Relative Strength Index (RSI)	44.22
Average Volume (20 Days)	7,913

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Elite Diagnostic had revenue of JMD 827.93 million and earned 20.19 million in profits. Earnings per share was 0.06.

Revenue	827.93M
Gross Profit	547.98M
Operating Income	85.46M
Pretax Income	23.39M
Net Income	20.19M
EBITDA	189.02M
EBIT	85.46M
Earnings Per Share (EPS)	0.06

Full Income Statement

Balance Sheet

The company has 45.88 million in cash and 435.70 million in debt, giving a net cash position of -389.83 million or -1.10 per share.

Cash & Cash Equivalents	45.88M
Total Debt	435.70M
Net Cash	-389.83M
Net Cash Per Share	-1.10
Equity (Book Value)	499.54M
Book Value Per Share	1.41
Working Capital	-39.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 160.08 million and capital expenditures -65.11 million, giving a free cash flow of 94.97 million.

Operating Cash Flow	160.08M
Capital Expenditures	-65.11M
Free Cash Flow	94.97M
FCF Per Share	0.27

Full Cash Flow Statement

Margins

Gross margin is 66.19%, with operating and profit margins of 10.32% and 2.44%.

Gross Margin	66.19%
Operating Margin	10.32%
Pretax Margin	2.82%
Profit Margin	2.44%
EBITDA Margin	22.83%
EBIT Margin	10.32%
FCF Margin	11.47%

Dividends & Yields

Elite Diagnostic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3.11%
FCF Yield	14.60%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Elite Diagnostic has an Altman Z-Score of 1.88. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.88
Piotroski F-Score	n/a